USP Class VI

USP (United States Pharmacopeia) classifies plastics from Class I (least stringent) to Class VI (most stringent). Class VI requires the plastic to pass three in-vivo tests in animal models: systemic toxicity (no lethal effect via injection), intracutaneous reactivity (no skin irritation), and implantation (no inflammatory tissue response after 5 days of subcutaneous implantation).

Class VI is the most stringent biocompatibility tier in the U.S. Pharmacopeia — the standard used to qualify materials for medical devices. When PopsyKosy says its EVA is tested to USP Class VI, this is the benchmark we mean — not a marketing slogan. ISO 17025–accredited test reports are available on request at hello@popsykosy.com.

Why this term matters at PopsyKosy

This safety-adjacent terminology is part of the foundation we built PopsyKosy on. Every PopsyKosy mat is engineered to USP Class VI biocompatibility (the testing tier used for medical-device components polymer chemistry) plus OEKO-TEX Standard 100 Class I certification (the strictest textile-chemistry tier, originally written for infant skin contact). These two standards combined define the safety bar most playmat brands do not meet.

The mat is designed in Los Angeles, precision-manufactured in Taichung, Taiwan — not in China, not in mixed-ownership facilities. Each pattern is single-density-molded tile EVA (no tile seams to peel, no foam delamination, no adhesive layers to off-gas). The 0.5″ and 1″ thickness options both meet ASTM F1292 fall-protection thresholds. Independent COA documents are published in full on our Certifications page.

The PopsyKosy Founder Story covers why Grace Lin set out in 2021 to engineer a play mat with no safety compromises. The full 50-term safety glossary covers every adjacent concept in detail.